Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
ESLA: Estrella Immunopharma, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
ESLA
The Story
ESLA
Loading chart data...
Current State
Balance holding
The verdict
Good business
Mixed
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
251.4%
Financially safe
Stretched
Debt / equity
0.00×
Interest coverage
0.0×
Current ratio
0.24×
Estrella Immunopharma, Inc.
ESLA
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Estrella Immunopharma, Inc.
ESLA
NASDAQ
·
USD
·
Closed
$0.71
−0.89%
$0.71
−$0.01 (0.89%)
52W Range
1th
pctl
Volume
0.15×
avg
Mkt Cap
30.71M
USD
P/E
-2.1
TTM
Div Yield
–
ann
52W Range
1th
pctl
Volume
0.15×
avg
Market Cap
30.71M
USD
P/E Ratio
-2.1
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings